Haplotype mismatched myeloablative stem cell transplantation: Phase I clinical trial of donor lymphocyte infusion depleted of alloreactive T cells to limit infections and malignant relapse without causing GVHD

被引：0
|
作者：
Roy, D. C. [1 ]
Cohen, S. [1 ]
Busque, L. [1 ]
Fish, D. [1 ]
Kiss, T. [1 ]
Lachance, S. [1 ]
Sauvageau, G. [1 ]
Caudrelier, P. [1 ]
Roy, J. [1 ]
机构：
[1] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
49
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Phase I clinical study of donor lymphocyte infusion depleted of alloreactive T cells after haplotype mismatched myeloablative stem cell transplantation to limit infections and malignant relapse without causing GVHD.
    Roy, Denis-Claude
    Cohen, Sandra
    Busque, Lambert
    Fish, Douglas
    Kiss, Thomas
    Lachance, Silvy
    Sauvageau, Guy
    Caudrelier, Pierre
    Roy, Jean
    BLOOD, 2006, 108 (11) : 96A - 96A
  • [2] DONOR LYMPHOCYTE INFUSIONS DEPLETED OF ALLOREACTIVE T CELLS DECREASE INFECTIONS WITHOUT CAUSING GVHD AFTER HAPLOTYPE MISMATCHED MYELOABLATIVE STEM CELL TRANSPLANTATION
    Roy, D-C
    Cohen, S.
    Busque, L.
    Fish, D.
    Kiss, T.
    Lachance, S.
    Sauvageau, G.
    Rovers, J.
    Roy, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 19 - 19
  • [3] Escalated-dose donor lymphocyte infusion depletion of alloreactive T-cells may limit infections and malignant relapse without causing GvHD after haplotype mismatched myeloablative stem cell transplantation
    Roy, D. C.
    Cohen, S.
    Busque, L.
    Fish, D.
    Kiss, T.
    Lachance, S.
    Sauvageau, G.
    Caudrelier, P.
    Roy, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S105 - S105
  • [4] Phase I clinical trial of haplotype mismatched myeloablative stem cell transplantation: Higher doses of donor lymphocyte infusions depleted of alloreactive cells using ATIR may improve outcome without causing GVHD
    Roy, Denis-Claude
    Cohen, Sandra
    Busque, Lambert
    Fish, Douglas
    Kiss, Thomas
    Lachance, Silvy
    Sauvageau, Guy
    Caudrelier, Pierre
    Roy, Jean
    BLOOD, 2007, 110 (11) : 874A - 874A
  • [5] Alloreactive T-cell depleted donor lymphocyte infusions decrease infections without causing severe GvHD after haplotype mismatched stem cell transplantation
    Roy, D. C.
    Lachance, S.
    Kiss, T.
    Cohen, S.
    Busque, L.
    Fish, D.
    Sauvageau, G.
    Rovers, J.
    Roy, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S2 - S2
  • [6] RISK-ADAPTED DONOR LYMPHOCYTE INFUSION TO PREVENT RELAPSE IS INDICATED IN ALL PATIENTS WITHOUT GVHD AFTER T CELL DEPLETED MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML
    Eefting, M.
    von dem Borne, P.
    Halkes, C.
    Kersting, S.
    Marijt, E.
    Veelken, J.
    Falkenburg, J.
    HAEMATOLOGICA, 2012, 97 : 722 - 722
  • [7] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [8] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [9] A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation
    Nikiforow, Sarah
    Kim, Haesook T.
    Daley, Heather
    Reynolds, Carol
    Jones, Kyle Thomas
    Armand, Philippe
    Ho, Vincent T.
    Alyea, Edwin P., III
    Cutler, Corey S.
    Ritz, Jerome
    Antin, Joseph H.
    Soiffer, Robert J.
    Koreth, John
    HAEMATOLOGICA, 2016, 101 (10) : 1251 - 1259
  • [10] Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd
    Roy, Denis-Claude
    Lachance, Silvy
    Kiss, Thomas
    Cohen, Sandra
    Busque, Lambert
    Fish, Douglas
    Sauvageau, Guy
    Egeler, Maarten
    Roy, Jean
    BLOOD, 2009, 114 (22) : 212 - 212
12345